Codexis (CDXS) Misses Q3 EPS by 18c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. GNK
5. USO
6. AZN
7. SPCX
8. UNG
9. FNGR
10. PLUR

Go back to Codexis (CDXS) Misses Q3 EPS by 18c

Codexis Reports Third Quarter 2023 Financial Results

November 2, 2023 4:05 PM EDT

Company Remains on Track to Demonstrate Gram-Scale Synthesis with ECO Synthesis Platform for RNAi Therapeutics Production by End of Year

Strong Financial Position Enables Projected Runway to Expected Positive Cash Flow Around End of 2026

Company to Host Virtual ECO Synthesis Platform-Focused KOL Event on December 8, 2023, featuring John Maraganore

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced financial results for the third quarter ended September 30, 2023,... More